« Previous
Next »
Annals of the ICRP
Volume 35, Issue 3
, Pages 13-29
, 2005
Chapters 2–4
References
- Implications of radioactive seed migration to the lungs after prostate brachytherapy. Urology. 2002;59:555–559
- Migration des grains d’iode 125 après curiethérapie prostatique: étude d’une série de 170 patients. Cancer/Radiothérapie. 2004;8:211–216
- Assessment of radiation safety instructions to patients based on measured dose rates following prostate brachytherapy. Brachytherapy. 2004;3:1–6
- Eckerman, K.F., Thompson, E.A., Veinot, K.G. Dose Coefficient for Deterministic Health Effects. ORNL/TM-2003/196. Oak Ridge National Laboratory, Oak Ridge, USA (in press).
- Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration. Int. J. Radiat. Oncol. Biol. Phys. 2004;59:419–425
- French Decree No. 2002-460, 2002. Journal Officiel de la République Française.
- Migration of iodine-125 and palladium-103 seeds to the lung after transperineal brachytherapy for prostate cancer. Endocurie/Hypertherm. Oncol. 1993;9:90
- IAEA, 1996. BSS Safety Series No. 115. Food and Agriculture Organization of the United Nations, International Atomic Energy Agency, International Labour Organization, OECD Nuclear Energy Agency, Pan American Health Organization, World Health Organization, Vienna.
- IAEA, 2002b. Advisory Material for the IAEA Regulations for the Safe Transport of Radioactive Materials. Safety Standards Series No. TS-G.1.1. International Atomic Energy Agency, Vienna.
- IAEA, 2003. Method for Developing Arrangements for Response to a Nuclear or Radiological Emergency. EPR-METHOD. International Atomic Energy Agency, Vienna.
- ICRP, 1977. Recommendations of the International Commission on Radiological Protection. ICRP Publication 26, Ann. ICRP.
- ICRP, 1991. 1990 Recommendations of the International Commission on Radiological Protection . ICRP Publication 60, Ann. ICRP 21(1–3).
- ICRP, 1996. Radiological protection and safety in medicine. ICRP Publication 73, Ann. ICRP 26.
- ICRU, 1992. Measurement of Dose Equivalents from External Radiation Sources – Part 2. ICRU Report No. 47. International Commission on Radiation Units and Measurement, Bethesda, MD.
- IRSN, 2003. Report SDOS 2003-009. Institut de Radioprotection et de Sûreté Nucléaire.
- Japanese Society for Therapeutic Radiology and Oncology, Japanese Urological Association and Japan Radiological Society, 2003. Guidelines for Safety Control of Brachytherapy with Permanently Implanted Sealed Seed Radiation Sources for Prostate Cancer. Japan Radioisotope Association, Tokyo. In Japanese.
- Seed fixity in the prostate/periprostatic region following brachytherapy. Int. J. Radiat. Oncol. Phys. 2000;46:215–220
- Radiation exposure to family and household members after prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 2003;56:764–768
- Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration. Urology. 1995;45:87–92
- . Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 1997;39:667–670
- Cremated remains should not be scattered in the environment until a minimum of ten half-lives has elapsed from the date of the implant (AAPM TG-56). Med. Phys. 1997;24:1557–1598
- NCRP, 1970. Precautions in the Management of Patients who have Received Therapeutic Amounts of Radionuclides. NCRP Report No. 37. National Council on Radiation Protection and Measurements, Bethesda, MD.
- NCRP, 1995. Use of Personal Monitors to Estimate Effective Dose Equivalent and Effective Dose to Workers for External Exposure to Low-LET Radiation. NCRP Report No. 122. National Council on Radiation Protection and Measurements, Bethesda, MD.
- NCRP, 1996. Screening Models for Releases of Radionuclides to Atmosphere, Surface Water, and Ground. NCRP Report No. 123. National Council on Radiation Protection and Measurements, Bethesda, MD.
- Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy. J. Urol. 2001;165:1590–1592
- . Radiation safety issues regarding the cremation of the body of a 125I prostate implant patient. J. Appl. Med. Phys. 2001;2:174–177
- Radiation safety parameters following prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 1999;45:397–399
- . Pulmonary embolization of iodine-125 seeds following prostate implantation. Urology. 1991;37:149–150
- Seed loss through the urinary tract after prostate brachytherapy: examining the role of cystoscopy and straining post-implant. Med. Phys. 2003;30:2695–2698
- Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 1998;42:1063–1067
- US NRC, 1988. A Regulatory Analysis on Emergency Preparedness for Fuel Cycle and Other Radioactive Material Licensees. US Nuclear Power Plants. NUREG-1140. US Nuclear Regulatory Commission, Washington, DC.
- US NRC, 2002. Consolidated Guidance about Material Licenses, Program-Specific Guidance about Medical Use Licenses. NUREG-1556. US Nuclear Regulatory Commission. U-1–U-27.
- . Pulmonary embolization of iodine-125 implants. AJR Am. J. Roentgenol. 1992;159:218
- Experimental incineration of low level radioactive samples. Health Phys. 2000;79(Suppl. 2):S25–S32
PII: S0146-6453(05)00013-8
doi: 10.1016/j.icrp.2005.07.002
« Previous
Next »
Annals of the ICRP
Volume 35, Issue 3
, Pages 13-29
, 2005
